Windrose Medical (NYSE:WRS)
Historical Stock Chart
From May 2019 to May 2024
INDIANAPOLIS, July 26 /PRNewswire-FirstCall/ -- Windrose Medical Properties Trust (NYSE:WRS), a self-managed specialty medical properties REIT, announced today that its Board of Trustees declared a quarterly dividend of $0.4726 per 7.5% Series A cumulative convertible preferred share for the second quarter ended June 30, 2006. This dividend will be payable on August 21, 2006 to preferred shareholders of record on August 4, 2006.
Beginning with the next quarterly dividend with a record date scheduled for November 5, 2006, Windrose will begin paying the dividend for the outstanding 7.5% Series A cumulative convertible preferred shares in four equal quarterly installments of $0.46875 per share as opposed to its current method of paying the dividend each quarter based on the number of days in the applicable period between record dates.
About Windrose
Windrose is a self-managed real estate investment trust (REIT) based in Indianapolis, Indiana with offices in Nashville, Tennessee. Windrose was formed to acquire, selectively develop and manage specialty medical properties, such as medical office buildings, ambulatory surgery centers, outpatient treatment and diagnostic facilities, and specialty hospitals and treatment centers.
Safe Harbor
Some of the statements in this news release constitute forward-looking statements. Such statements include, in particular, statements about our beliefs, expectations, plans and strategies that are not based on historical facts. You should not rely on our forward-looking statements because the matters they describe are subject to known and unknown risks, uncertainties, assumptions and changes in circumstances, many of which are beyond our control, which may cause our actual results to differ significantly from those expressed in any forward- looking statement. The factors that could cause actual results to differ materially from current expectations include adverse changes in healthcare laws, changes in economic and general business conditions, competition for specialty medical properties, our ability to finance our operations, regulatory conditions and other factors described from time to time in filings we make with the Securities and Exchange Commission. The forward-looking statements contained herein represent our judgment as of the date hereof, and we caution readers not to place undue reliance on such statements. We do not undertake to publicly update or revise any forward- looking statement whether as a result of new information, future events or otherwise.
Contact:
Windrose Medical Properties Trust
Fred Farrar
President and COO
(317) 860-8213
Investors/Media:
The Ruth Group
Stephanie Carrington/Jason Rando
(646) 536-7017/7025
DATASOURCE: Windrose Medical Properties Trust
CONTACT: Fred Farrar, President and COO of Windrose Medical Properties
Trust, +1-317-860-8213; or Investors - Stephanie Carrington, +1-646-536-7017,
, or Media - Jason Rando, +1-646-536-7025,